ABBVX

AbbVie xStock

$225,68
2,46%
ABBVxSPLSOLXswbinNKyPmzTa5CskMbCPvMW6G5CMnZXZEeQSSQoie2025-06-12
AbbVie xStock (ABBVx) is a Solana-based tokenised certificate reflecting AbbVie Inc. stock. Issued by Backed Finance, it enables on-chain access to the underlying equity for eligible participants.

xStocks are digital tokens that represent fractional ownership of specific U.S.-listed stocks or exchange-traded funds (ETFs). Each token corresponds 1:1 to an underlying asset, which is held in custody by Backed Finance. Issued on the Solana blockchain, xStocks allow for transfer and trading of these representations on-chain. They are used for purposes such as trading on supported exchanges, portfolio diversification, and participation in certain decentralised finance (DeFi) applications.

AbbVie xStock (ABBVx) is a tokenised tracker certificate designed to reflect the price of AbbVie Inc. stock (NYSE: ABBV). It is issued on the Solana blockchain. The product enables eligible participants to gain on-chain exposure to AbbVie Inc. through a regulatory-compliant structure.

The underlying asset is issued by AbbVie Inc., a U.S.-based biopharmaceutical company focused on developing therapies in immunology, oncology, neuroscience, and eye care. Its portfolio includes established treatments like Humira and a pipeline of newer products across therapeutic areas.

  • Issuer: Backed Assets (JE) Limited
  • ISIN: CH1436219393
  • Network / Chain: Solana (SOL)
  • Smart Contracts: Solana

  • Issuer: AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, USA
  • LEI: FR5LCKFTG8054YNNRU85
  • ISIN: US00287Y1091
  • Symbol: ABBV
  • Name: AbbVie Inc.

  • Tokenizer: Backed Finance AG
  • Brokers: Alpaca Securities LLC, InCore Bank AG, Maerki Baumann & Co. AG
  • Custodians: Alpaca Securities LLC, InCore Bank AG, Maerki Baumann & Co. AG
  • Security Agent: Security Agent Services AG

xStocks are issued by Backed Finance, a Swiss-based company focused on tokenising traditional financial assets. Access to these tokens is restricted to non-U.S. persons in accordance with applicable regulations.